Database Mining Analysis Revealed the Role of the Putative H/sugar Transporter Solute Carrier Family 45 in Skin Cutaneous Melanoma

Overview

Journal Channels (Austin)

Specialty Biochemistry

Date 2021 Aug 2

PMID 34334114

Citations 19

Authors

Jiaheng Xie

Shujie Ruan

Zhechen Zhu

Ming Wang

Yuan Cao

Mengmeng Ou

Pan Yu

Jingping Shi

Affiliations

Soon will be listed here.

Abstract

Metabolic reprogramming is common in various cancers. Targeting metabolism to treat tumors is a hot research topic at present. Among them, changes in glucose metabolism in cancer have been widely studied. The Warburg effect maintains a high metabolic level in the tumor, accompanied by changes in glucose transporters. The transmembrane transport of sugar was previously thought to be mediated by SGLT and GLUT. Recently, the Solute Carrier Family(SLC) 45 family may be the third sugar transporter. But the role and value of the SLC45 family in melanoma, a highly malignant skin tumor, is unclear. Our study found that the four members of the SLC45 family, SLC45A1-SLC45A4, were differentially expressed in melanoma, but only SLC45A2 and SLC45A3 had prognostic guiding values. Further analysis revealed that the co-expression patterns of SLC45A2 and SLC45A3 were enriched in multiple metabolic pathways, suggesting their potential role in melanoma. In addition, SLC45A2 and SLC45A3 are also associated with immune cell infiltration. In conclusion, SLC45A2 and SLC45A3 are good prognostic indicators for melanoma and have guiding value for the treatment of melanoma in the future.

Citing Articles

SLC45A4 is involved in malignant progression of ovarian cancer through glycolytic metabolic reprogramming.

Xu Y, Han X, You S, Zhu W, Zhang M, Lu C Sci Rep. 2024; 14(1):23031.

PMID: 39363015 PMC: 11450204. DOI: 10.1038/s41598-024-74249-z.

Analysis of Active Components and Transcriptome of Callus Extract and Its Effects against Oxidative Stress and Wrinkles in Skin.

Kim E, De Tollenaere M, Sennelier B, Lambert C, Durduret A, Kim S Int J Mol Sci. 2024; 25(15).

PMID: 39125720 PMC: 11311438. DOI: 10.3390/ijms25158150.

THEM6 is a prognostic biomarker for breast cancer and is associated with immune infiltration.

Lu X, Chen W, Tian G, Ge F Sci Rep. 2023; 13(1):21974.

PMID: 38081884 PMC: 10713618. DOI: 10.1038/s41598-023-49379-5.

Solute carrier family 35 member A2 (SLC35A2) is a prognostic biomarker and correlated with immune infiltration in stomach adenocarcinoma.

Huang Z, Yang H, Lao J, Deng W PLoS One. 2023; 18(7):e0287303.

PMID: 37467193 PMC: 10355401. DOI: 10.1371/journal.pone.0287303.

Multi-Omics Analysis and Verification of the Oncogenic Value of CCT8 in Pan-Cancers.

Gong L, Zhong M, Gong K, Wang Z, Zhong Y, Jin Y J Inflamm Res. 2023; 16:2297-2315.

PMID: 37273485 PMC: 10238552. DOI: 10.2147/JIR.S403499.

References

Srour M, Shimokawa N, Hamdan F, Nassif C, Poulin C, Al Gazali L . Dysfunction of the Cerebral Glucose Transporter SLC45A1 in Individuals with Intellectual Disability and Epilepsy. Am J Hum Genet. 2017; 100(5):824-830. PMC: 5420346. DOI: 10.1016/j.ajhg.2017.03.009. View

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

Marzagalli M, Ebelt N, Manuel E . Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment. Semin Cancer Biol. 2019; 59:236-250. DOI: 10.1016/j.semcancer.2019.08.002. View

Queirolo P, Boutros A, Tanda E, Spagnolo F, Quaglino P . Immune-checkpoint inhibitors for the treatment of metastatic melanoma: a model of cancer immunotherapy. Semin Cancer Biol. 2019; 59:290-297. DOI: 10.1016/j.semcancer.2019.08.001. View

Schneebauer G, Mauracher D, Fiechtner B, Pelster B . Transcript levels of members of the SLC2 and SLC5 families of glucose transport proteins in eel swimbladder tissue: the influence of silvering and the influence of a nematode infection. Fish Physiol Biochem. 2018; 44(2):599-613. PMC: 5862955. DOI: 10.1007/s10695-017-0456-y. View

Chandrashekar D, Bashel B, Balasubramanya S, Creighton C, Ponce-Rodriguez I, Chakravarthi B . UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia. 2017; 19(8):649-658. PMC: 5516091. DOI: 10.1016/j.neo.2017.05.002. View

Pascale R, Calvisi D, Simile M, Feo C, Feo F . The Warburg Effect 97 Years after Its Discovery. Cancers (Basel). 2020; 12(10). PMC: 7599761. DOI: 10.3390/cancers12102819. View

Le L, Escobar I, Ho T, Lefkovith A, Latteri E, Haltaufderhyde K . SLC45A2 protein stability and regulation of melanosome pH determine melanocyte pigmentation. Mol Biol Cell. 2020; 31(24):2687-2702. PMC: 7927184. DOI: 10.1091/mbc.E20-03-0200. View

Tomczak K, Czerwinska P, Wiznerowicz M . The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Pozn). 2015; 19(1A):A68-77. PMC: 4322527. DOI: 10.5114/wo.2014.47136. View

10.

Bai X, Moraes T, Reithmeier R . Structural biology of solute carrier (SLC) membrane transport proteins. Mol Membr Biol. 2018; 34(1-2):1-32. DOI: 10.1080/09687688.2018.1448123. View

11.

Gao J, Aksoy B, Dogrusoz U, Dresdner G, Gross B, Sumer S . Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013; 6(269):pl1. PMC: 4160307. DOI: 10.1126/scisignal.2004088. View

12.

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu J . TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017; 77(21):e108-e110. PMC: 6042652. DOI: 10.1158/0008-5472.CAN-17-0307. View

13.

Vitavska O, Wieczorek H . Putative role of an SLC45 H/sugar cotransporter in mammalian spermatozoa. Pflugers Arch. 2017; 469(11):1433-1442. PMC: 5629229. DOI: 10.1007/s00424-017-2024-9. View

14.

Reina-Campos M, Moscat J, Diaz-Meco M . Metabolism shapes the tumor microenvironment. Curr Opin Cell Biol. 2017; 48:47-53. PMC: 5650101. DOI: 10.1016/j.ceb.2017.05.006. View

15.

Mulukutla B, Yongky A, Le T, Mashek D, Hu W . Regulation of Glucose Metabolism - A Perspective From Cell Bioprocessing. Trends Biotechnol. 2016; 34(8):638-651. DOI: 10.1016/j.tibtech.2016.04.012. View

16.

Biswas S . Metabolic Reprogramming of Immune Cells in Cancer Progression. Immunity. 2015; 43(3):435-49. DOI: 10.1016/j.immuni.2015.09.001. View

17.

Luengo A, Gui D, Vander Heiden M . Targeting Metabolism for Cancer Therapy. Cell Chem Biol. 2017; 24(9):1161-1180. PMC: 5744685. DOI: 10.1016/j.chembiol.2017.08.028. View

18.

Rastrelli M, Tropea S, Rossi C, Alaibac M . Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. In Vivo. 2014; 28(6):1005-11. View

19.

Sciacovelli M, Frezza C . Metabolic reprogramming and epithelial-to-mesenchymal transition in cancer. FEBS J. 2017; 284(19):3132-3144. PMC: 6049610. DOI: 10.1111/febs.14090. View

20.

Lin Y, Chen X, Yang Y, Che F, Zhang S, Yuan L . Mutational Analysis of TYR, OCA2, and SLC45A2 Genes in Chinese Families with Oculocutaneous Albinism. Mol Genet Genomic Med. 2019; 7(7):e00687. PMC: 6625147. DOI: 10.1002/mgg3.687. View